Benitec Biopharma Ltd (BLT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Benitec Biopharma Ltd (BLT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12161
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based therapeutics for various conditions such as hepatitis B, wet age-related macular degeneration and OPMD. The company also licenses ddRNAi to various biopharmaceutical companies for the development of drugs. The company has research laboratories in Hayward, California, the US. Benitec is headquartered in Sydney, New South Wales, Australia.

Benitec Biopharma Ltd (BLT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Benitec Biopharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Benitec Biopharma Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Benitec Biopharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Benitec Biopharma Ltd, Medical Equipment, Deal Details 10
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 10
Equity Offering 11
Benitec Biopharma Raises USD4.7 Million in Rights Offering of Shares 11
Benitec Biopharma to Raise USD2 Million in Private Placement of American Depositary Shares 12
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$28 Million 13
Benitec Biopharma Ltd – Key Competitors 15
Benitec Biopharma Ltd – Key Employees 16
Benitec Biopharma Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
May 31, 2018: Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update 18
May 31, 2018: Benitec Biopharma: Interim Report for the nine months ended March 31, 2018 20
Feb 22, 2018: Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update 21
Nov 29, 2017: Benitec Biopharma reports financial results for the 2018 fiscal first quarter and provides operational update 23
May 30, 2017: Benitec Biopharma : Interim Report for the nine months ended March 31, 2017 25
Corporate Communications 26
Sep 19, 2018: Benitec Biopharma names Gregory R. Reyes as senior scientific advisor 26
Oct 23, 2017: Benitec announces resignation of Director, Dr John Chiplin 27
Oct 12, 2017: Benitec announces the appointment of a new Chairman 28
Oct 10, 2017: Benitec announces resignation of Chief Business and Operations Officer 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Benitec Biopharma Ltd, Medical Equipment, Key Facts, 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Benitec Biopharma Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Deals By Market, 2012 to YTD 2018 8
Benitec Biopharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Benitec Biopharma Enters Into Licensing Agreement With University of New South Wales For Tribetarna 10
Benitec Biopharma Raises USD4.7 Million in Rights Offering of Shares 11
Benitec Biopharma to Raise USD2 Million in Private Placement of American Depositary Shares 12
Benitec Biopharma Completes Second Tranche Of Private Placement Of Shares For US$28 Million 13
Benitec Biopharma Ltd, Key Competitors 15
Benitec Biopharma Ltd, Key Employees 16
Benitec Biopharma Ltd, Other Locations 17
Benitec Biopharma Ltd, Subsidiaries 17

List of Figures
Benitec Biopharma Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Benitec Biopharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Benitec Biopharma Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Benitec Biopharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Benitec Biopharma Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Benitec Biopharma Ltd (BLT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Correvio Pharma Corp (CORV):企業の財務・戦略的SWOT分析
    Correvio Pharma Corp (CORV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Curemark LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, …
  • Haverty Furniture Companies, Inc. (HVT):企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • S.A.G. Solar GmbH & Co KG:電力:M&Aディール及び事業提携情報
    Summary S.A.G. Solar GmbH & Co. KG. (S.A.G. Solar) a subsidiary of Shunfeng International Clean Energy Limited, is a manufacturer of photovoltaic systems. The company constructs, installs, operates and integrates solar power plants. It constructs rooftop systems, roof and facade-integrated systems, …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Natus Medical Incorporated (BABY):医療機器:M&Aディール及び事業提携情報
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. It offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus offers products for diagnostic hearing assessment in child …
  • FTS International Inc (FTSI):企業の財務・戦略的SWOT分析
    FTS International Inc (FTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MGP Ingredients Inc (MGPI):企業の財務・戦略的SWOT分析
    MGP Ingredients Inc (MGPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ingles Markets Inc:企業の戦略・SWOT・財務情報
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • Buck Institute for Research on Aging-製薬・医療分野:企業M&A・提携分析
    Summary Buck Institute for Research on Aging (Buck Institute) is a healthcare institute that conducts research and offers educational services. The institute concentrates on understanding the connection between aging and chronic disease. It works to understand how normal aging contributes to the dev …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PetroChina Company Limited:企業の戦略・SWOT・財務情報
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Orsted AS (ORSTED):石油・ガス:M&Aディール及び事業提携情報
    Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and …
  • Mayo Foundation for Medical Education and Research:企業の戦略的SWOT分析
    Mayo Foundation for Medical Education and Research - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆